LyondellBasell improves CDP climate score to A in 2024, strengthening ESG leadership — Neutral
LYB GlobeNewsWire — July 14, 2025HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has improved its climate change score from A-minus to A in CDP's 2024 assessment, placing the company in the leadership category for the second consecutive year. CDP is the world's leading environmental disclosure platform, used by investors and stakeholders to evaluate how companies manage climate-related risks, opportunities and performance.

Applied Digital Sets Fiscal Fourth Quarter and Full Year 2025 Conference Call for Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time — Neutral
APLD GlobeNewsWire — July 14, 2025DALLAS, July 14, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the "Company"), a designer, builder, and operator of next-generation digital infrastructure designed for High-Performance Computing (HPC) applications, will host a conference call on Wednesday, July 30, 2025, at 5:00 p.m. Eastern Time to discuss its operations and financial results for the fiscal fourth quarter and full year ended May 31, 2025.

Norwegian Cruise Line Holdings to Hold Conference Call on Second Quarter 2025 Financial Results — Neutral
NCLH GlobeNewsWire — July 14, 2025MIAMI, July 14, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd.

Applebee's 2 for $25 Menu Adds NEW Chicken Parmesan Fettuccine and NEW BIG Bangin' Burger — Neutral
DIN Business Wire — July 14, 2025PASADENA, Calif.--(BUSINESS WIRE)--Applebee's favorite two-person pairing, the 2 for $25 deal, just got better. Now for a limited time, guests can enjoy the NEW Chicken Parmesan Fettuccine, NEW BIG Bangin' Burger, or fan-favorite Oriental Chicken Salad, paired with an appetizer or two side salads for only $25!* Savor the taste of summer with every bite of these delicious entrées, available for dine-in, To Go, or delivery, all for an unbeatable value. Perfect for any occasion, whether celebratin.

Casella Waste Systems, Inc. Signs Agreement For Acquisition Of West Virginia-Based Mountain State Waste — Neutral
CWST GlobeNewsWire — July 14, 2025RUTLAND, Vt., July 14, 2025 (GLOBE NEWSWIRE) -- Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company (the “Company”), today announced that it has signed an agreement for the acquisition of the assets of Mountain State Waste.

TopBuild to Release Second Quarter 2025 Results on Tuesday, August 5 — Neutral
BLD GlobeNewsWire — July 14, 2025DAYTONA BEACH, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced it will release its second quarter 2025 results prior to 7:00 a.m.

Genius Group increases Bitcoin Treasury 22% to 180 Bitcoin, achieves 161% BTC Yield. — Neutral
GNS GlobeNewsWire — July 14, 2025SINGAPORE, July 14, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on July 12, 2025 it purchased 32 Bitcoin, increasing its Bitcoin Treasury by 22% to 180 Bitcoin, at an average price of $105,568. The Company has achieved 161% BTC Yield since May 22, 2025, when a Preliminary Injunction (“PI”) preventing the Company from purchasing Bitcoin was stayed by the U.S. Court of Appeals.

Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025 — Neutral
QSI Business Wire — July 14, 2025BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025.

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer — Neutral
CORT Business Wire — July 14, 2025REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its proprietary, selective cortisol modulator, relacorilant, to treat patients with platinum-resistant o.

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 — Neutral
TWST Business Wire — July 14, 2025SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 third quarter ended June 30, 2025, before the opening of the market on August 4, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financ.

indie's LXM-U Laser Powers Next-Gen Quantum Technologies with Ultra-Low Noise Performance — Neutral
INDI Business Wire — July 14, 2025ALISO VIEJO, Calif.--(BUSINESS WIRE)--indie (Nasdaq: INDI), an automotive solutions innovator, is rapidly gaining industry adoption in its photonics portfolio, with indie's latest ultra-low noise LXM-U lasers enabling next-generation quantum applications by delivering industry-leading frequency stability and integration flexibility. indie's Photonics Business Unit (BU) was established earlier this year, combining our photonics team (formerly TeraXion) in Canada, with a portfolio of laser and op.

Atara Biotherapeutics Provides Regulatory and Business Updates on Tabelecleucel (Tab-cel®) — Neutral
ATRA Business Wire — July 14, 2025THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that it has resubmitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tabelecleucel (EBVALLO™ or tab-cel®) indicated as monotherapy for treatment of adult and pedi.

IonQ Appoints Paul T. Dacier as Chief Legal Officer and Corporate Secretary — Neutral
IONQ Business Wire — July 14, 2025COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), a leader in the quantum computing and networking industries, today announced the appointment of Paul T. Dacier as Chief Legal Officer and Corporate Secretary, effective immediately. Dacier succeeds Stacey Giamalis, who will remain at IonQ in an advisory capacity for up to 90 days to ensure a smooth transition of responsibilities. Dacier is a highly accomplished executive and legal advisor to innovative companies in the technology and data s.

Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong — Neutral
ALBT GlobeNewsWire — July 14, 2025FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the Hong Kong Intellectual Property Department (HKIPD) for its proprietary CAR-T and CAR-Natural Killer (NK) cell technology.

Consensus Cloud Solutions Announces Closing of New Credit Facility — Neutral
CCSI Business Wire — July 14, 2025LOS ANGELES--(BUSINESS WIRE)--Consensus Cloud Solutions, Inc. (NASDAQ: CCSI), (the “Company”) has entered into a Credit Agreement (the “Credit Agreement”) with certain lenders party (the “Lenders”) and U.S. Bank National Association, as agent on July 9, 2025. Pursuant to the Credit Agreement, the Lenders have provided the Company with a senior secured revolving credit facility of $75.0 million and a senior secured delayed-draw term loan facility of $150.0 million (collectively, the “Credit Faci.

DDC Enterprise Launches DDC Bitcoin Influence Collective to Accelerate Growth and Enhance Shareholder Value — Neutral
DDC Business Wire — July 14, 2025NEW YORK--(BUSINESS WIRE)--DDC Enterprise Limited (NYSE: DDC) (“DDC” or the “Company”), a leading US-listed bitcoin treasury company, today announced the launch of the DDC Bitcoin Influence Collective (“BIC”), a transformative initiative designed to accelerate DDC's growth strategy, strengthen its leadership in the bitcoin sector, and drive long-term value for shareholders. The inaugural members of the DDC Bitcoin Influence Collective are Adrian Morris, Lemar Ashhar, Magdalena Gronowska, and Ti.

Esri Collaborates with Microsoft to Bring ArcGIS Users New AI Enhancements — Neutral
MSFT Business Wire — July 14, 2025REDLANDS, Calif.--(BUSINESS WIRE)--Esri, the global leader in geographic information system (GIS) technology, is integrating Microsoft Azure OpenAI Service into ArcGIS. This powerful collaboration equips users with all new AI assistants to simplify work with geospatial data, maps, and analytics. In addition, the AI's natural language interaction will enable users to quickly understand complex spatial problems. By automating spatial analyses, AI-enhanced GIS can enable organizations of all sizes.

Shift4 Selected by TIME as One of America's Best Mid-Size Companies — Neutral
FOUR Business Wire — July 14, 2025CENTER VALLEY, Pa.--(BUSINESS WIRE)--Shift4 (NYSE: FOUR), the leader in integrated payments and commerce technology, has been named to TIME's list of America's Best Mid-Size Companies 2025. This prestigious recognition, presented annually by TIME and Statista Inc., acknowledges Shift4's exceptional performance across employee satisfaction, revenue growth, and sustainability transparency. Shift4 delivers an end-to-end commerce solution for businesses across numerous industries, including retail,.

Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 — Neutral
GH Business Wire — July 14, 2025PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2025 after market close on Wednesday, July 30, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.guardanthealth.com. The webcast will.

NiCE Actimize X-Sight AML Solutions Selected by Aberdeen Group to Enhance Its Financial Crime Operations — Neutral
NICE Business Wire — July 14, 2025HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NiCE Actimize, a NiCE (NASDAQ: NICE) business, today announced that Aberdeen Group, a UK-based global investment management firm headquartered in Edinburgh, has selected NiCE Actimize's X-Sight Suspicious Activity Monitoring (SAM) and Watch List Screening solutions as part of its financial crime operations. These are part of NiCE Actimize's advanced portfolio of anti-money laundering (AML) solutions which address financial services institutions' (FIs) most pressi.
